Fernando Pacheco
Partner
Fernando is a Partner at Endeavour Vision, leading investments across a range of therapeutic areas. He brings 15 years of medtech experience spanning industry, strategy consulting and venture investing.
He led investments in Miach Orthopaedics and Virtual Incision, co-led CeQur, and serves as a board director at all three. He was a board observer at SOPHiA GENETICS (NASDAQ: SOPH) ahead of its 2021 IPO.
Previously, Fernando was an Engagement Manager at McKinsey & Co, running strategy and organisational projects for medical device and pharmaceutical clients across Europe, the US and Brazil. Earlier, he was a project engineer at Stryker Trauma & Extremities, developing orthopaedic trauma implants.
Fernando holds an MEng in Biomedical Engineering from Imperial College London, including a year at ETH Zürich.